04:34 PM EDT, 06/26/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on June 24, 2024, sold 8,301 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,917,475. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 80,941 shares of the company, with 80,534 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000068/xslF345X03/edgardoc.xml

Price: 244.43, Change: -0.74, Percent Change: -0.30